Onward Assist
- Company typePrivate
- Founded2016
- HeadquartersHyderabad, India
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Onward Assist firmographics
Firmographics- Name
- Onward Assist
- Legal name
- Inventigen Technologies Pvt. Ltd.
- Website
- https://onwardassist.ai
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Onward Assist industry classification
Industry- Product category
- Digital Pathology Software
- NAICS
- Computer Systems Design Services (541512)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)
- akta.pro secondary industries
- Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ), Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)
Keywords
Where Onward Assist is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Offices3 records
Markets served
Onward Assist business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software Licenses and Subscriptions: AI-assisted pathology reporting software sold as subscription-based or pay-per-use licensing. Flexible pricing models available including subscription-based or pay per use case. Deployment on cloud or on-premises.
- Lab Management Software: LabNetX platform for diagnostic lab operations with different payment models based on intended use and scale.
- Professional Services and Consulting: Ad-hoc consulting services and implementation support for digital pathology deployment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Hybrid | Pay-as-you-go | Flexible Pricing Model |
| Usage-based | Pay-as-you-go | LabNetX Payment Models |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Onward Assist product offering
Product offeringCore offering
Onward Assist builds and sells an AI-powered cancer analytics and digital pathology software platform composed of PathAssist (AI engine for cancer biomarker quantification on whole slide images), PathFlowDx (digital pathology workflow and case management), Slide Scholar (academic pathology training platform), and LabNetX (lab operations management for diagnostic testing). The platform helps pathologists and diagnostic labs produce faster, more accurate cancer diagnoses with deployment options across cloud and on-premises environments.
Product overview
Onward Assist is a cancer analytics platform offering a suite of digital pathology tools. The platform operates as a modular ecosystem comprising four integrated products: PathAssist (AI-powered image analysis engine for cancer metric prediction), PathFlowDx (digital pathology workflow and case management system), Slide Scholar (academic training platform for digital pathology), and LabNetX (lab operations management for RT-PCR and diagnostic testing). The solutions can be deployed on cloud or on-premises and are designed to assist pathologists in making precise cancer diagnosis decisions with reduced reporting time.
Differentiator
Problem solved
Functional benefit
Brands
- PathAssist: AI-powered pathology assistant that analyzes digital pathology images and quantifies important metrics using proprietary artificial intelligence algorithms for cancer diagnosis.
- PathFlowDx
- Slide Scholar
- LabNetX
Products and services
- PathAssist PathAssist is an AI-powered pathology assistant that analyzes digital pathology images and quantifies important cancer metrics using proprietary artificial intelligence algorithms, helping pathologists report more slides in less time with greater accuracy. It supports multiple algorithms for different organs, tumor sites, and markers, with 6 algorithms available for research use and additional algorithms under clinical trial. It is targeted at pathologists, diagnostic labs, and hospital pathology departments and can be deployed via cloud or on-premises.
- PathFlowDx PathFlowDx is a smart workflow management solution for digital pathology case management, tracking, logging, and reporting. It includes user-friendly annotation tools, smart reporting with pre-populated standard protocol templates aligned to CAP protocols, and case allocation management. It integrates with Laboratory Information Management Systems (LIMS), EMR systems, and digital pathology scanners, and is designed for hospital pathology departments and diagnostic labs seeking to maximize utilization of digital pathology infrastructure.
- Slide Scholar Slide Scholar is an academic training platform for digital pathology education that enables efficient and contextual training with integrated annotation tools, image library access, and simultaneous multiple viewers functionality. It is targeted at academic medical centers and pathology training institutions seeking to build a pipeline of pathologists comfortable with digital pathology tools.
- LabNetX LabNetX is a cloud-based lab workflow management system designed for diagnostic labs to manage operational requirements for reporting RT-PCR and other microscopy tests. It provides customizable dashboards, preloaded report templates, sample tracking, and integration with lab machines including RT-PCR machines. It is targeted at large diagnostic lab networks and clinical labs needing operational efficiency and regulatory reporting.
Quantifiable outcome
- 30-40% reduction in pathology reporting time
- +3 more outcomes
Companies that use Onward Assist
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
Onward Assist technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability4 records
Feature4 records
Onward Assist partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Molpax Bio Co. Ltd (S. Korea)coreMoU signed in online ceremony for collaboration to develop new computational pathology tools. Partnership aims to combine strengths in advancing digital pathology solutions internationally.
- GE HealthcarecoreSelected for GE Healthcare India Edison Accelerator second cohort. Receives mentorship, strategic partnerships, and access to Edison platform for co-developing healthcare solutions. Zero-equity cash grant of $10,000 provided.
- GINSEP/GIZ GermanyminorCollaboration through CEFE International, GIZ GmbH, BMWi, Invest India, NASSCOM, and MeitY Startup Hub for startup delegation trip to Germany. Program included 11-step market entry support and Demo Day.
- EIT HealthcoreSelected for Bridgehead programme to expand presence to European and global markets. Gains access to EIT Health's network of partners for connections and market expansion support.
- Lumos AcceleratorcoreSelected for speed scaling programme providing clinical, technical and business advisory. Offers infrastructure credits to defray operating expenses for early-stage healthcare startups.
- Yale UniversitycoreCollaboration with Yale University to improve AI technology and create models for better analysis of cancer pathology data.
- AIIMS DelhicorePartnership with premier government medical institution for digital pathology deployment and research collaboration.
- CB InsightsminorListed on CB Insights as a recognized AI/healthtech startup company.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Onward Assist competitors and assessment
Company assessmentDirect peers
- Proscia: Proscia offers a digital pathology platform with AI applications, workflow tools, and integrations for cancer diagnosis. Its Concentriq platform overlaps directly with Onward Assist's PathFlowDx and AI engine capabilities, serving similar lab and biopharma customers.
- PathAI: PathAI is a direct competitor building AI algorithms for pathology diagnosis and partnering with pharma and diagnostic labs. It targets the same pathologist and pathology lab buyer segment with AI-driven biomarker quantification and cancer diagnosis, but operates at significantly larger scale with substantially more funding.
- Paige.AI: Paige builds AI-based pathology applications for cancer diagnosis with FDA-cleared products (e.g., Paige Prostate) and serves hospital and reference lab customers. It is a direct competitor to PathAssist, with stronger regulatory clearance and clinical evidence.
- Ibex Medical Analytics: Ibex develops AI-based cancer diagnostics for pathology, deployed in routine clinical use at hospital and reference labs globally. It directly competes with Onward Assist on AI-powered cancer diagnosis in pathology, with multiple CE-marked products.
- Owkin: Owkin applies AI to pathology and clinical research, including federated learning approaches for biomarker discovery. It overlaps with Onward Assist's AI pathology analysis and biomarker quantification, though Owkin also extends into pharma drug development.
Regional players
- SigTuple: SigTuple is an India-based AI healthtech company applying computer vision and machine learning to microscopy and pathology workflows. Comparable as an India-centric AI diagnostics peer with overlap in slide analysis use cases for clinical labs.
Emerging players
- Qritive: Qritive develops AI-powered diagnostic tools for pathology, including cancer cell detection and classification. It is an emerging AI pathology competitor with similar target customers (pathology labs, hospitals) and overlapping product scope with Onward Assist's PathAssist.
- AIRA Matrix: AIRA Matrix provides AI-based diagnostic solutions for pathology and radiology, with focus on the Indian and global markets. Comparable to Onward Assist in target customers (pathology labs, hospitals) and AI diagnostic use cases, though broader in modality.
Broad incumbents
- Philips (Digital Pathology): Philips offers an established digital pathology solution including whole-slide imaging scanners, workflow software, and AI integrations through its IntelliSite Pathology Solution. It is a broad incumbent competing with PathFlowDx in workflow and PathAssist indirectly through partnered AI algorithms.
- Roche (Digital Pathology): Roche offers the Ventana digital pathology portfolio including scanners, image management software, and AI algorithm partnerships. As a broad incumbent in anatomic pathology, it competes with Onward Assist's end-to-end stack at the enterprise level, especially in larger hospital networks.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Onward Assist social profiles
Digital presenceOnward Assist financial estimates
Financial estimateRevenue estimate
Valuation estimate
Onward Assist leadership team
Management profileNumber of profiles
Profiles3 records
Onward Assist funding detail
Funding detailFunding overview
Funding rounds6 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Onward Assist M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Onward Assist
What does Onward Assist do?
Onward Assist builds and sells an AI-powered cancer analytics and digital pathology software platform composed of PathAssist (AI engine for cancer biomarker quantification on whole slide images), PathFlowDx (digital pathology workflow and case management), Slide Scholar (academic pathology training platform), and LabNetX (lab operations management for diagnostic testing). The platform helps pathologists and diagnostic labs produce faster, more accurate cancer diagnoses with deployment options across cloud and on-premises environments.
Is Onward Assist a public or private company?
Onward Assist is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Onward Assist founded?
Onward Assist was founded in 2016. It employs 11 to 50 people.
Where is Onward Assist based?
Onward Assist is headquartered in Hyderabad, India, in the Asia region.
How does Onward Assist make money?
Three revenue lines are on record. Software Licenses and Subscriptions are the primary driver. The others are lab Management Software and professional Services and Consulting.
Who are Onward Assist's main competitors?
Direct peers on record are Proscia, PathAI, Paige.AI, Ibex Medical Analytics and Owkin. SigTuple is listed as a regional player. Emerging players are Qritive and AIRA Matrix. Broad incumbents are Philips (Digital Pathology) and Roche (Digital Pathology).
Does Onward Assist have an API?
No public API is recorded for Onward Assist.
What industry is Onward Assist in?
Onward Assist's product category is Digital Pathology Software. Its primary akta.pro industry code is HLAAALAO, Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays), with a secondary code of HLACAMAJ, Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces. Its NAICS code is 541512 and its SIC code is 7372.